Making the right choices in manufacturing and testing early is critical for gaining regulatory approval and achieving patient access faster. Charles River’s suite of cell and gene therapy solutions can support your drug’s entire lifecycle, from discovery to commercialization. We have supported the development of 24 FDA-approved cell and gene therapies and have conducted more than 1,000 studies in this field over the past year.
Ready to unlock the future of cell and gene therapy? Join our Cell and Gene Therapy Online Course on September 3rd. Whether you're an industry expert or just starting out, course this is your key to the latest advancements, regulatory insights, and practical solutions. Our integrated approach combines R&D with CMC and biologics testing, ensuring seamless knowledge transfer, reduced bottlenecks, and accelerated drug development. From discovery to commercialization, we'll help you achieve your critical development goals faster.
Don't miss this opportunity to learn from experts, connect with industry peers, and stay ahead of the curve. Register now and take the next step in your CGT journey!